|
|
|
|
Suppliers for
Fidaxomicin
|
Properties | | CAS |
873857-62-6 | | Formula |
C52H74Cl2O18 |
|
13 Registered suppliers
Molecular Formula: C51H72Cl2O19
Molecular Weight: 1060.01198
Molecular Formula: C51H72Cl2O19
Molecular Weight: 1060.01198
Molecular Formula: C51H72Cl2O19
Molecular Weight: 1060.01198
Molecular Formula: C51H72Cl2O19
Molecular Weight: 1060.01198
Molecular Formula: C51H72Cl2O19
Molecular Weight: 1060.01198
Description : Fidaxomicin (OPT-80; PAR-101) is a new class of narrow spectrum macrocyclic antibiotic drug; selective eradication of pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria that make up the normal, healthy intestinal flora. - Molecular Weight :1058.04
- Boiling Point :1046.4°C at 760 mmHg
- Melting Point :143-145°C
- Purity :≥98%
Molecular Formula : C52H74Cl2O18 Canonical SMILES : CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C
InChI :
InChI=1S/C52H74Cl2O18/c1-13-30-22-26(6)33(56)18-16-15-17-31(23-66-51-45(65-12)42(61)44(29(9)67-51)69-49(64)35-32(14-2)36(53)39(58)37(54)38(35)57)48(63)68-34(28(8)55)20-19-25(5)21-27(7)43(30)70-50-41(60)40(59)46(52(10,11)72-50)71-47(62)24(3)4/h15-17,19,21-22,24,28-30,33-34,40-46,50-51,55-61H,13-14,18,20,23H2,1-12H3/b16-15+,25-19+,26-22+,27-21+,31-17+/t28-,29-,30+,33+,34+,40-,41+,42+,43+,44-,45+,46+,50-,51-/m1/s1
InChIKey :
ZVGNESXIJDCBKN-UUEYKCAUSA-N
Solubility :
Sparingly soluble in methanol; slightly soluble in water and insoluble in chloroform.
Appearance :
White Powder
Application :
One of the first narrow spectrum macrocyclic antibiotic; FDA approved on May 27, 2011
Storage : Store at-20°C
Synonyms :
OPT80; OPT-80; OPT 80; PAR101; PAR 101; PAR-101; Fidaxomicin; 3-(((6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-b-D-mannopyranosyl)oxy)-methyl)-12(R)-[(6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-b-D-lyxo-hexopyranosyl)oxy]-11(S)-ethyl-8(S)-hydroxy-18(S)-(1(R)-hydroxyethyl)-9,13,15-trimethyloxacyclooctadeca-3,5,9,13,15-pentaene-2-one; R-Tiacumicin B; FidaxoMicin(LipiarMycin); ClostoMicin B1; LipiarMycin A3; TiacuMicin B; Oxacyclooctadeca-3,5,9,13,15-pentaen-2-one, 3-[[[6-deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-β-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-, (3E,5E,8S,9E,11S,12R,13E,15E,18S)-
More details are to be found here
Description : Fidaxomicin (OPT-80; PAR-101) is a new class of narrow spectrum macrocyclic antibiotic drug; selective eradication of pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria that make up the normal, healthy intestinal flora. - Molecular Weight :1058.04
- Boiling Point :1046.4°C at 760 mmHg
- Melting Point :143-145°C
- Purity :≥98%
Molecular Formula : C52H74Cl2O18 Canonical SMILES : CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C
InChI :
InChI=1S/C52H74Cl2O18/c1-13-30-22-26(6)33(56)18-16-15-17-31(23-66-51-45(65-12)42(61)44(29(9)67-51)69-49(64)35-32(14-2)36(53)39(58)37(54)38(35)57)48(63)68-34(28(8)55)20-19-25(5)21-27(7)43(30)70-50-41(60)40(59)46(52(10,11)72-50)71-47(62)24(3)4/h15-17,19,21-22,24,28-30,33-34,40-46,50-51,55-61H,13-14,18,20,23H2,1-12H3/b16-15+,25-19+,26-22+,27-21+,31-17+/t28-,29-,30+,33+,34+,40-,41+,42+,43+,44-,45+,46+,50-,51-/m1/s1
InChIKey :
ZVGNESXIJDCBKN-UUEYKCAUSA-N
Solubility :
Sparingly soluble in methanol; slightly soluble in water and insoluble in chloroform.
Appearance :
White Powder
Application :
One of the first narrow spectrum macrocyclic antibiotic; FDA approved on May 27, 2011
Storage : Store at-20°C
Synonyms :
OPT80; OPT-80; OPT 80; PAR101; PAR 101; PAR-101; Fidaxomicin; 3-(((6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-b-D-mannopyranosyl)oxy)-methyl)-12(R)-[(6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-b-D-lyxo-hexopyranosyl)oxy]-11(S)-ethyl-8(S)-hydroxy-18(S)-(1(R)-hydroxyethyl)-9,13,15-trimethyloxacyclooctadeca-3,5,9,13,15-pentaene-2-one; R-Tiacumicin B; FidaxoMicin(LipiarMycin); ClostoMicin B1; LipiarMycin A3; TiacuMicin B; Oxacyclooctadeca-3,5,9,13,15-pentaen-2-one, 3-[[[6-deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-β-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-, (3E,5E,8S,9E,11S,12R,13E,15E,18S)-
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
|
Properties:
... more properties and specification on Fidaxomicin
|
|
Privileged suppliers
Last update 2024-06-09
|
_Co_Ltd_1_575.jpg){kind=logo}
details
details